|
Research Interests:
Dr. Triulzi's interest are in transfusion support of stem cell and solid organ transplant recipients and immunomodulatory effects of transfusion. He site PI for the NIH Transfusion Medicine/Hemostasis Clinical Trials Network. Current research projects include:
- Optimal platelet dosing in patients with hematologic malignancy
- Leukoreduction in cardiac surgery
- Red cell transfusion triggers
Selected Publications:
View Dr. Triulzi's publications on PubMed.
Triulzi DJ. Transfusion support in liver transplantation. Curr Hematol Rep. 2004 Nov;3(6):444-9
Fung MK, Rao N, Rice J, Ridenour M, Mook W, Triulzi DJ. Leukoreduction in the setting of open heart surgery:a prospective cohort-controlled study. Transfusion 2004;44:30-35.
Bell CF, Botteman MF, Gao X, Weissfeld JL, Postma MJ, Pashos CL, Triulzi DJ, Staginnus U. Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States. Clin Therap 2003;25:2464-2486.
Brecher ME, Triulzi DJ, Assman S. Number of RBC units and rate of transfusion in anemic HIV-positive patients assigned to WBC-reduced or non-WBC-reduced RBC: The Viral Activation by Transfusion Study experience. Transfusion 2001;41:794-8.
Triulzi DJ, Meyer EM, Donnenberg AD. WBC subset analysis of WBC-reduced platelet components. Transfusion 2000;40:771-80.
| 
